| Document Date: 2014-09-25 14:17:47
Open Document File Size: 276,60 KBShare Result on Facebook
City Orlando / Titusville / / Company YouTube / Janssen Scientific Affairs LLC / Janssen Pharmaceuticals Inc. / Twitter / / Country United States / / Event Reorganization / Company Expansion / FDA Phase / / IndustryTerm sustainable and integrated healthcare solutions / machinery / healthcare / healthcare professionals / healthcare professional / / MedicalCondition torsades de pointes / clinically significant neutropenia / Seizures / congenital long QT syndrome / Leukopenia / hallucinations / schizophrenia start / extrapyramidal disorder / cerebrovascular disease / Syncope / complex brain disorder / Schizophrenia JANSSEN / hypersensitivity / Neuroleptic Malignant Syndrome / drug-induced leukopenia/neutropenia / muscle rigidity / transient ischemic attacks / Agranulocytosis / Hyperprolactinemia / hypotension / schizophrenia / disease / Schizophrenia Schizophrenia / hyperglycemia / cardiac arrhythmias / chronic / Neutropenia / dyslipidemia / stroke / cardiovascular disease / fever / seizure / schizophrenia initiate / Orthostatic Hypotension / Diabetes Mellitus / infection / hyperosmolar coma / dizziness / Tardive Dyskinesia / syndrome / disorders / akathisia / dehydration / / Organization Study Observed Association / Congress / / Person Catherine Tak Piech / Robyn Frenze / / / Position physician / nurse / Vice President / Health Economics and Outcomes Research / / Product INVEGA / carbamazepine / risperidone / rifampin / olanzapine / Atypical Long-Acting Injectable Antipsychotic / INVEGA® SUSTENNA / / ProvinceOrState New Jersey / / PublishedMedium Health Economics / / Technology alpha / / URL www.YouTube.com/JanssenUS / www.JanssenPharmaceuticalsInc.com / www.twitter.com/JanssenUS / www.InvegaSustenna.com / www.Invega.com / /
SocialTag |
Media Contact: Robyn Frenze[removed]office[removed]mobile) Study Observed Association between JANSSEN® CONNECT® Injection Centers and Increased Adherence to Healthcare Provider-Ordered Janssen Long-Acting